Mungmun Pharmaceutical Executive Raises Stake to 0.84%
Executive Jung Jun-il bought 7,000 common shares on the open market, increasing his stake from 0.82% to 0.84% on Oct. 23, 2026.
Executive Jung Jun-il bought 7,000 common shares on the open market, increasing his stake from 0.82% to 0.84% on Oct. 23, 2026.